Novel Nonsense Mutation in SMARCD2 Gene Results in Dysplasia of All Myeloid Cell Lines
Open Access
Abstract
Introduction: Specific granule deficiency type II (SGD2) is a rare heterogeneous congenital disease characterized by early‐onset life‐threatening infections. SGD2 is caused by autosomal recessive mutations in the SMARCD2 gene. Methods: Prenatal screening in our patient revealed a novel homozygous nonsense mutation in SMARCD2 (c.208C>T, p.Gln70*). Results: Postnatally, she suffered from infections, pneumonia, cholestasis, mucocutaneous bleeding, and dysmorphic features, including clubfoot. Hematological findings included neutropenia, monocytosis, myelodysplasia, and thrombocytopenia. In contrast to previous cases, this patient presented with dysplasia of all myeloid lineages, including hypogranular neutrophils, pseudo Pelger–Huët, macrothrombocytes, bilobular monocytes, and dysplastic erythroblasts. Due to the severity of her condition, she passed away after 1.5 months. Conclusion: This report illustrates the role of SMARCD2 in hematopoiesis and provides an overview of all previously described SGD2 patients. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.Keywords
This publication has 11 references indexed in Scilit:
- Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 MutationsHematology Reports, 2022
- Specific Granule Deficiency Due To Novel Homozygote SMARCD2 VariantPediatric Allergy, Immunology, and Pulmonology, 2022
- EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunityBone Marrow Transplantation, 2021
- Diagnostic exome-based preconception carrier testing in consanguineous couples: results from the first 100 couples in clinical practiceGenetics in Medicine, 2021
- Defective neutrophil development and specific granule deficiency caused by a homozygous splice-site mutation in SMARCD2Journal of Allergy and Clinical Immunology, 2021
- Novel Frameshift Autosomal Recessive Loss-of-Function Mutation in SMARCD2 Encoding a Chromatin Remodeling Factor Mediates GranulopoiesisJournal of Clinical Immunology, 2020
- Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytesNature Genetics, 2017
- SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanismNature Genetics, 2017
- Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomesNature Reviews Molecular Cell Biology, 2015
- Transcriptional control of granulocyte and monocyte developmentOncogene, 2007